Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Rhinomed

Rhinomed
PUBLIC STATUS
RNO STOCK SYMBOL
2 INVESTMENTS
$0.10 SHARE PRICE (As of Friday Closing)
Description

Rhinomed Ltd is a medical technology company, with a patented nasal technology platform. It is engaged in research, development and commercialization of consumer and medical devices including nasal, respiratory and nasal drug delivery technologies.

Formerly Known As
Consegna Group
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Therapeutic Devices
Stock Exchange
ASX
Primary Office
  • 97 Green Street
  • Cremorne, Victoria 3121
  • Australia

+61 (03) 0000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Rhinomed’s full profile, request a free trial.

Rhinomed Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$0.10 - $0.29 $14.7M $0.10 167K 142M

Rhinomed Financials Summary

In Thousands,
USD
TTM
31-Dec-2019
FY 2019
30-Jun-2019
FY 2018
30-Jun-2018
FY 2017
30-Jun-2017
Enterprise Value 19,871 19,676 12,647 12,031
Revenue 2,350 1,680 1,294
EBITDA (3,969) (2,882) (3,306)
Net Income (4,248) (3,102) (3,347)
Total Assets 4,112 4,340 4,950
Total Debt 0 0 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Rhinomed Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Rhinomed‘s full profile, request access.

Request full access to PitchBook

Rhinomed Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 0000000 22-Dec-2011 000000000000000000 00.00 Surgical Devices
Leading Edge Instruments 24-Feb-2011 Merger/Acquisition Medical Supplies
To view this company’s complete investment and acquisition history, request access »

Rhinomed Subsidiaries (1)

Company Name Industry Location Founded
00000 0000000 Surgical Devices Marlborough, MA 0000
To view this company’s complete subsidiary history, request access »

Rhinomed Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Rhinomed‘s full profile, request access.

Request full access to PitchBook

Rhinomed Executive Team (2)

Name Title Board
Seat
Contact
Info
Michael Johnson Chief Executive Officer & Managing Director
Brooks George Account Executive